Home Blood Pressure Intervention in the Community Trial

Recruiting N/A Interventional Study
Home Blood Pressure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
10,000 (estimated)
Sponsor
Shanghai Institute of Hypertension · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary purpose of the study is to explore whether a lower home blood pressure target (125/75 v.s. 135/85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged 60-80 years old * Have been taking antihypertensive drugs for more than 2 weeks * The average SBP and/or DBP of 7-day home blood pressure monitoring ≥135/85 mmHg * Willing to participate, adhere to follow-up, and sign the written informed consent form Exclusion Criteria:…
Contacts

Yan Li, Professor

+8613482234463

liyanshcn@163.com

CONTACT